Private Equity Firms

Thoma Bravo

Thoma Bravo is a PE firm that backs tech-focused businesses.

Venture Investor Overview

Venture Investor
Thoma Bravo
Status
InActive
Investor Type
Private Equity
Activity Level
29 transactions
Funds Raised
At least $1.1 billion
Industry Focus
Artificial Intelligence
Blockchain
Enterprise IT
FinTech
Healthcare Services
Internet & IoT
Mobile
Security
Software
Transportation

Contact Information

Contact
Orlando Bravo
Title
Managing Partner
Mailing Address
600 Montgomery St. 20th Floor
San Francisco, CA 94111
USA
Phone
(415) 263-3660
Website
www.thomabravo.com
Email Address
Not Recorded

Background Information

Overview
Thoma Bravo targets control investments in companies with strong business franchises led by experienced executives who aspire to achieve industry leadership. We work in close partnership with a company's management team to implement operating best practices and use our consolidation expertise to rapidly improve earnings and increase equity value. Thoma Bravo invests in many industries and has particular expertise in software, business and financial services, education, and other consolidating industry sectors.
Profile
Thoma Bravo LinkedIn Company Profile
Social Media
Thoma Bravo Company Twitter Account
Company News
Thoma Bravo News
Facebook
Thoma Bravo on Facebook
YouTube
Thoma Bravo on YouTube
Last Transaction
11/9/2022

Transaction History

Our records indicate that Thoma Bravo invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
TRM Labs
11/9/2022
$70,000,000
Alation
11/2/2022
$123,000,000
SMA Technologies
10/4/2022
Unknown
Alma
8/25/2022
$130,000,000
Aisera
8/3/2022
$90,000,000
FalconX
6/22/2022
$150,000,000
AppOmni
6/6/2022
$70,000,000
Imply
5/17/2022
$100,000,000
Personetics
1/27/2022
$85,000,000
project44
1/12/2022
$240,000,000
Paradox
12/28/2021
$200,000,000
Figment
12/21/2021
$110,000,000
Anchorage
12/16/2021
$350,000,000
Pendo
11/12/2021
$110,000,000
FTX
7/22/2021
$900,000,000
ServiceTitan
7/2/2021
$200,000,000
Illumio
6/25/2021
$225,000,000
Venafi
12/11/2020
Unknown
Global Healthcare Exchange
5/18/2017
Unknown
SailPoint Technologies
8/13/2014
Unknown
SRS Software
1/3/2013
Unknown
Excel Energy Technologies
3/31/2008
$1,500,000
Altheus Therapeutics
9/19/2007
$3,600,000
Spine Wave
4/10/2007
$45,000,000
US Renal Care
7/10/2006
$36,000,000
Jazz Pharmaceuticals
3/31/2006
$35,000,000
Made2Manage Systems
1/9/2006
$50,000,000
Continuing Care Rx
6/30/2005
$45,000,000
Jazz Pharmaceuticals
3/24/2004
$250,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Partner
Seth Boro
  Seth Boro LinkedIn Profile  Seth Boro Twitter Account  Seth Boro News  Seth Boro on Facebook
Managing Partner
Orlando Bravo
  Orlando Bravo LinkedIn Profile  Orlando Bravo Twitter Account  Orlando Bravo News  Orlando Bravo on Facebook
Managing Partner
Scott Crabill
  Scott Crabill LinkedIn Profile  Scott Crabill Twitter Account  Scott Crabill News  Scott Crabill on Facebook
Partner
Jack Le Roy
  Jack Le Roy LinkedIn Profile  Jack Le Roy Twitter Account  Jack Le Roy News  Jack Le Roy on Facebook
Managing Partner
Lee Mitchell
  Lee Mitchell LinkedIn Profile  Lee Mitchell Twitter Account  Lee Mitchell News  Lee Mitchell on Facebook
Managing Director
Erwin Mock
  Erwin Mock LinkedIn Profile  Erwin Mock Twitter Account  Erwin Mock News  Erwin Mock on Facebook
Partner
AJ Rohde
  AJ Rohde LinkedIn Profile  AJ Rohde Twitter Account  AJ Rohde News  AJ Rohde on Facebook
Partner
Robert Sayle
  Robert Sayle LinkedIn Profile  Robert Sayle Twitter Account  Robert Sayle News  Robert Sayle on Facebook
Partner
Hudson Smith
  Hudson Smith LinkedIn Profile  Hudson Smith Twitter Account  Hudson Smith News  Hudson Smith on Facebook
Managing Partner
Holden Spaht
  Holden Spaht LinkedIn Profile  Holden Spaht Twitter Account  Holden Spaht News  Holden Spaht on Facebook
Managing Partner
Carl Thoma
  Carl Thoma LinkedIn Profile  Carl Thoma Twitter Account  Carl Thoma News  Carl Thoma on Facebook

 

Funds

Our database includes the following fund closing(s) for Thoma Bravo. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Thoma Bravo Discover Fund
2/16/2016
$1,074,000,000

 

Portfolio Companies

Thoma Bravo has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Aisera
Alation
Alma
Altheus Therapeutics
Anchorage
AppOmni
Continuing Care Rx
Excel Energy Technologies
FalconX
Figment
FTX
Global Healthcare Exchange
Illumio
Imply
Jazz Pharmaceuticals
Made2Manage Systems
Paradox
Pendo
Personetics
project44
SailPoint Technologies
ServiceTitan
SMA Technologies
Spine Wave
SRS Software
TRM Labs
US Renal Care
Venafi

 

 

 

 

Browse more private equity investors:

Third Point | Thomas H. Lee Partners

 

Share this article

 

About Our Private Equity Investor Database

This PE firm profile is powered by VentureDeal.com, a leading provider of private equity tech investment transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.